Microfluidics which manipulate small volumes of fluid in microchannels enable gentle manipulation of cells and molecules and precise control of experimental conditions.It allows miniaturization of bulk assays in small devices requiring small volumes of samples and reagents and integration of several components for multiplexing analysis and achieving higher throughput.
This research explores the advantages and challenges of traditional as well as emerging materials and fabrication technologies for the point-of-care applications.Various nanofluidic phenomena being investigated for point-of-care diagnosis is also reported.
The report also covers some of the remarkable innovations in different segments of the industry, and also lists OEM manufacturing companies supporting innovations in the field. The drivers and challenges of the microfluidics and nanofluidics-based point-of-care diagnostics industry are explored in detail.
Notable funding and acquisition activities in the last three years are also investigated. The growth opportunities offered by autonomous microfluidic devices, 3D printing, flexible microfluidics and integration with information technologies are discussed. Strategic recommendations to succeed in the space are also put forth. In addition to the above, this research service also offers insights on the IP landscape and the key patents in the last six years.
Our reports have been used by over 10K customers, including:
185 pages •
By Global Industry Analysts
• Apr 2021
- Global Diagnostic Specialty Enzymes Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Diagnostic Specialty Enzymes estimated at US$769 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.